The substance
What is BPC-157?
The substance is real. The bigger question is what has been shown to help people.
- Researchers based it on a piece of a protein reported in human stomach juice.
- Different ingredients have been marketed under the name BPC-157. That name by itself cannot identify the ingredient inside.
- That link to a stomach-juice protein does not prove that injecting lab-made BPC-157 is safe.
The evidence
What have studies in people shown?
As of September 28, 2026, only a few small studies in people are available.
Start by asking who was studied. A finding in rats answers a different question from a finding in people with pain.
Animal work
- A tendon is a tough cord that joins muscle to bone. A study published in 2003 tested rats with cut tendons. Their healed tendons took more weight before tearing after BPC-157 than after salt water.
- These were rats with cut tendons, not people recovering from an injury.
Human reports
- Across the five human studies the FDA found, about 80 people received BPC-157 in total.
- A trial for ulcerative colitis, a bowel disease, did not give the FDA enough evidence to support BPC-157 treatment.
- The knee-pain report had no comparison group: similar people who did not get BPC-157. It also had no set way to measure how much people improved.
- That report cannot tell us whether the substance caused people to feel better.
Trials in progress
- A muscle-strain trial in China was still enrolling people, with no results reported as of September 28, 2026.
- A registered US study after shoulder surgery had not begun enrolling people by September 28, 2026.
What would make the answer clearer?
Look for a comparison group: similar people who did not get the substance.
- Ask what happened to that group.
- Ask what was measured and how long people were followed.
The rules
A prescription does not settle the rules.
Compounding means making the patient’s medicine rather than relying on a drug company’s finished product.
- Compounded medicines, as of September 26, 2026, lack approval from the FDA. Before sale, they receive no FDA check of their quality, safety or benefit.
- As of September 26, 2026, federal rules bar an ordinary pharmacy from using raw ingredients to prepare BPC-157 for a named patient.
- A prescription does not override those ingredient rules.
What does taking back a request mean?
Some groups asked the FDA to let pharmacies make medicines with BPC-157. The FDA now lists those requests as “withdrawn,” meaning the groups took them back.
- That FDA page is marked current to April 22, 2026. It does not say when the requests were taken back.
- Taking back a request did not grant permission for pharmacy use.
- The FDA still lists its safety concerns next to BPC-157.
What about official-looking codes?
An NDC, short for National Drug Code, identifies a product in the FDA’s drug directory.
- As of September 26, 2026, an NDC code is not proof of approval.
- For a business, FDA registration is no proof of approval for the products it offers, as of September 26, 2026.
The visit
Begin the visit with the concern that brought you.
Write down what hurts, when it began, and what it keeps you from doing. Bring your question about the substance into that conversation.
A clinician is a health professional who checks your health and talks with you about a plan.
- In-person care
Ask how the clinician will assess the concern and explain the usual care options.
- Telehealth
Telehealth brings care to you through a video link, a telephone call or an exchange online. You are not in the room with the health professional.
Ask whether this type of visit can assess your concern, and how any examination or test you need would be set up.
Check the doctor’s licence
A state medical board gives doctors licences—permission to practise medicine. It posts whether each licence is current. It also posts the public actions it has taken when a doctor breaks the board’s rules.
- The board directory in this chapter’s endnotes leads to each state’s own website.
- As of September 26, 2026, telehealth guidance calls for a doctor to be licensed or otherwise authorised where the patient is during the visit.
- Each state’s rules govern; there is no single national medical licence, as of September 26, 2026.
- A record without public action against the doctor does not show whether the care is good or poor.
Look for room to ask questions
Boards that issue doctors’ licences belong to one organisation: the Federation of State Medical Boards.
- Proper care takes more than selecting a treatment on a menu, says the group’s May 2026 guidance.
- Patients should also get a chance to ask more questions, according to that guidance.
Ask who will assess you, and how to reach that person after the visit.
The bill
Ask for the whole bill.
As of September 28, 2026, no medicine containing BPC-157 is approved. There is no approved product with a price published by a drug company or a government programme.
For any care offer, ask for the full amount in writing before agreeing.
- The visit
What is the charge to assess my concern, even if no medicine is prescribed?
- Tests
Which tests would be included, and which would be billed separately?
- Follow-up
Is another visit included? Is there a repeating membership payment?
- Treatment
If treatment is proposed, what is its separate charge?
- Insurance
What will my plan pay for the visit, tests and treatment? Ask the plan to confirm each item.
- Leaving
What are the cancellation and refund terms?
The unknowns
What is known about harm?
As of September 28, 2026, the FDA says the available human studies cannot establish how safe BPC-157 is.
- The small studies appeared to report no serious side effects. They were short, and most did not clearly explain how researchers checked people for health problems.
- The immune system is the body’s defence against germs. The FDA warns that this defence might react against BPC-157 if it is injected or sprayed into the nose. Such reactions can cause no noticeable problem, or can be life-threatening.
- The FDA review had found no study formally testing these reactions to BPC-157 as of September 28, 2026.
- No FDA-reviewed BPC-157 label explains its use in pregnancy or with other medicines, as of September 28, 2026.
Offers worth stepping back from
Ask for the evidence behind reassuring language. A label or test sheet needs a careful look too.
- Treat an “FDA approved” claim for BPC-157 as a red flag: no approval exists as of September 28, 2026.
- The words “research use only” on a label do not mean the FDA has checked the product for human use, as of September 28, 2026.
- A test sheet showing how pure an ingredient is does not prove an injection has no germs. It also does not prove it has no bacterial toxins: harmful substances made by bacteria, a kind of germ.
If sport rules apply to you
Under the World Anti-Doping Agency’s rules, BPC-157 is prohibited both during and outside competition, as of September 28, 2026.
- Ask your sport’s governing body which rules apply before agreeing to a treatment plan.
When urgent help comes first
A swollen tongue or severe trouble breathing may signal a dangerous allergic reaction.
- Severe symptoms need emergency care: dial 911 or head to an emergency room.
The conversation
Take these questions into the visit.
You can ask plain questions and ask again if an answer is hard to follow. Bring a note of the goal that matters to you.
- What could explain my symptoms?
- What usual care options fit the problem?
- What has been tested in people with this same problem?
- If BPC-157 is offered, what is the full name of the ingredient, and who would make it?
- Given the rules above, why is the pharmacy offering to make BPC-157 from raw ingredients? Please show me the written federal rule you rely on and explain it in plain words.
- A batch is a supply made at one time. Can you explain the tests on the batch I would receive? Were there checks for germs, harmful substances made by bacteria, and small bits that do not belong in the medicine?
- Who do I reach after the visit, and what is the plan if things change?
- How will progress be judged, and what would change the plan?
Checks for germs or unwanted material do not prove that BPC-157 is safe for people.
Start with your own goal
Write a sentence about what you want help doing again. Take it along with the questions above.